Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · Mar 24, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at the sleep quality of young people who have survived cancer. It focuses on patients aged 15 to 24 who received cancer treatment during their teenage years and young adulthood. The researchers want to understand how cancer treatments might affect sleep patterns in these individuals, especially since many already struggle with sleep issues. They will gather information through questionnaires about how often participants experience insomnia, which is trouble sleeping, at moderate to severe levels.

To be eligible for this study, participants must have been treated for cancer when they were between 15 and 24 years old and have completed their intensive treatment at least three months prior. They also need to be able to understand French and have a life expectancy of at least six months. Participants can expect to fill out a questionnaire that will help the researchers learn more about their sleep experiences after cancer treatment. This information could be valuable in improving care and support for young cancer survivors in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient treated for a cancer
• • Patient aged between 15 and 24 years old at the time of the diagnosis
• • Patients whom intensive treatment ended at least 3 months ago
• • Patient followed in a PACAAURA cancerology center
• • Life expectancy ≥ 6 months
• • Karnosky index \> 60%
• • Patient who agrees to participate in the program and benefits from social security
• • Patient able to understand, speak and read French.
• • No major cognitive impairment (assessed by the patient's referees)
• • No sensory disability
• Exclusion Criteria:
• • Patient unable to use informatic tools
• • Known superior cognitive function disorders
• • Progressive psychiatric pathology
• • Drug user or alcohol abuse